The role of microRNA in gastric malignancy

Toshihiro Nishizawa1, Hidekazu Suzuki

  • 1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. hsuzuki@a6.keio.jp.

Insights

Helicobacter pylori (H. pylori) infection drives gastric diseases. MicroRNAs (miRNAs) show complex roles in gastric cancer, offering potential for novel chemoprevention strategies targeting miRNA regulation.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gastroenterology

Background:

  • Helicobacter pylori (H. pylori) infection is a primary cause of gastritis, ulcers, and gastric cancer.
  • MicroRNAs (miRNAs) are small noncoding RNAs regulating gene expression and are crucial in cell functions like proliferation and apoptosis.

Purpose of the Study:

  • To summarize the biological significance of miRNAs in gastric malignancy.
  • To explore the dual roles of miRNAs in gastric cancer development and progression.

Main Methods:

  • Literature review and synthesis of current research on miRNAs in gastric cancer.
  • Analysis of studies investigating miRNA involvement in gastric carcinogenesis and potential therapeutic applications.

Main Results:

  • miRNAs are implicated in gastric malignancy, with some promoting and others inhibiting cancer progression.
  • Certain miRNAs have been linked to reduced inflammation, suppressed malignancy, and enhanced apoptosis of cancer cells.
  • Dysregulation of miRNA expression is a hallmark of gastric cancer.

Conclusions:

  • miRNAs play multifaceted roles in gastric cancer, acting as both oncogenes and tumor suppressors.
  • Targeting miRNA expression represents a promising novel strategy for the chemoprevention of human gastric malignancy.
  • Understanding miRNA biology is crucial for developing new therapeutic interventions for gastric cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...